Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:42:00.610Z.
Calculation as of: 2026-10-06T15:42:00.610Z.
Quote observation: 2026-10-06T15:40:33.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5aadd97284981d173c87413c67de95801d58f7ce8cc73935cbfc70b12a62615a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Generate Biomedicines, Inc.
Market Cap
$1.78B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Operating Cash Flow Yield
N/A
TTM Avg
9.83%
3Y Avg
9.83%
5Y Avg
9.83%
Market Cap
$1.83B
Operating Cash Flow Yield
4.55%
TTM Avg
3.60%
3Y Avg
2.74%
5Y Avg
2.82%
Market Cap
$1.73B
Operating Cash Flow Yield
11.90%
TTM Avg
5.31%
3Y Avg
4.07%
5Y Avg
4.23%
Market Cap
$1.84B
Operating Cash Flow Yield
9.56%
TTM Avg
8.87%
3Y Avg
6.19%
5Y Avg
5.71%
Market Cap
$1.84B
Operating Cash Flow Yield
0.08%
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
0.72%
Market Cap
$1.72B
Operating Cash Flow Yield
18.54%
TTM Avg
11.27%
3Y Avg
10.47%
5Y Avg
9.16%
Market Cap
$1.71B
Operating Cash Flow Yield
N/A
TTM Avg
0.81%
3Y Avg
0.81%
5Y Avg
0.81%
Market Cap
$1.85B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Generate Biomedicines, Inc. (GENB) | $1.78B | N/A | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.74B | N/A | 9.83% | 9.83% | 9.83% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.83B | 4.55% | 3.60% | 2.74% | 2.82% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.73B | 11.90% | 5.31% | 4.07% | 4.23% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 9.56% | 8.87% | 6.19% | 5.71% |
| Novocure Ltd (NVCR)vs › | $1.84B | 0.08% | 0.08% | 0.08% | 0.72% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.72B | 18.54% | 11.27% | 10.47% | 9.16% |
| Personalis, Inc. (PSNL)vs › | $1.71B | N/A | 0.81% | 0.81% | 0.81% |
| Absci Corporation (ABSI)vs › | $1.85B | N/A | N/A | N/A | N/A |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.87B | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
